Monoclonal antibodies to human interferon-gamma. I. Antibodies to a synthetic carboxyl-terminal peptide. 1985

Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto

Two types of hybridomas secreting monoclonal antibodies (MAB) against human interferon-gamma (HuIFN-gamma) were obtained by somatic cell hybridization between mouse myeloma P3U1 cells and spleen cells from BALB/c mice immunized with a conjugate of a synthetic carboxyl-terminal peptide (residues 131-146) of HuIFN-gamma and bovine thyroglobulin. One of the antibodies bound to recombinant HuIFN-gamma produced in E. coli as well as to natural HuIFN-gamma, while the others bound only to recombinant HuIFN-gamma. These 2 types of MAB did not neutralize the anti-viral activity of HuIFN-gamma. They were useful for effectively purifying recombinant HuIFN-gamma and quantitatively determining it by an enzyme-linked immunosorbent assay.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013954 Thyroglobulin
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
January 1994, The Journal of biological chemistry,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
December 1983, Biochemical and biophysical research communications,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
May 1986, Journal of immunology (Baltimore, Md. : 1950),
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
January 1991, Voprosy virusologii,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
January 1988, Microbiology and immunology,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
April 1987, Hybridoma,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
October 1991, Hybridoma,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
January 1984, Journal of interferon research,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
January 1993, Immunology series,
Y Ichimori, and T Kurokawa, and S Honda, and N Suzuki, and M Wakimasu, and K Tsukamoto
January 1983, The EMBO journal,
Copied contents to your clipboard!